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The purpose of this study was to screen key survival-related genes from patients with colorectal cancer and explore signal 
transduction network of the involved genes. In a previous study, survival-related genes of patients with colorectal cancer were 
selected by colorectal cancer-related expression data GSE17538 using the Significance Analysis of Microarrays (SAM3.01) 
software, and 235 genes related to the survival of patients with colorectal cancer were obtained. Therefore, the following 
screening and analysis were conducted on these 235 genes in this study. First, the enrichment analysis of transcription factor 
binding sites was conducted on the 235 genes. Genes with more than seven transcription factor binding sites were screened. Then, 
these genes and upregulated genes in colorectal cancer were intersected. Finally, survival analysis and regulatory network 
analysis were conducted on the screened genes. This allowed clarification of the relationship between these genes and the sur-
vival of patients with colorectal cancer and the signaling network involving these genes in the cell signal transduction network 
of colorectal cancer. Through the above analysis, six upregulated genes in colorectal cancer related to the survival of colorectal 
cancer patients and highly regulated by transcription factors were selected, namely STX2, PODXL, KLK6, GRB10, EHBP1 and 
CREB5. These genes are involved in signal regulatory networks related to colorectal cancer metastasis-related signaling path-
ways. Therefore, the survival of patients with colorectal cancer is closely correlated with colorectal cancer metastasis. The six 
survival-related genes affect the survival of patients by regulating colorectal cancer metastasis-associated signaling pathways. 
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The survival time of patients with colorectal cancer is in-
fluenced by many factors. During the actual study, changes 
in the expression of some genes in colorectal cancer cells 
affected the survival time and prognosis of patients with 
colorectal cancer. Therefore, clarifying the molecular 
mechanisms of changes in the survival time of colorectal 
cancer patients has important significance for guiding the 
treatment of colorectal cancer and evaluating prognosis. In a 
previous study, survival time-related genes of colorectal 
cancer patients were screened from the expression profiling 
data GSE17538 in the GEO database of NCBI using signif-
icance analysis software SAM3.01 [1]. A total of 235 sur-
vival time-related genes of colorectal cancer patients were 
obtained, and KEGG pathway enrichment analysis showed 
that these genes were closely related to colorectal cancer 
metastasis. In this study, further analysis was conducted 
primarily on the 235 survival time-related genes, and rela-
tively important genes were screened by regulatory network 
analysis on interactions of the proteins encoded by these 
genes. The effects of these genes on the survival time of 
patients with colorectal cancer were illustrated. 
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1  Materials and methods 
First, enrichment analysis was conducted on transcription 
factor binding sites in the transcription regulatory regions of 
the 235 genes described above using the Transcription Fac-
tor Matrix Explorer (TFM-Explorer) tool [2]. Some tran-
scription factor binding sites (TFBS) existed in multiple 
genes simultaneously, indicating there were more surviv-
al-related genes regulated by these transcription factors. 
Sequencing was conducted according to scores to screen 
and obtain the set of this type of transcription factor binding 
sites. The transcription regulatory regions of many genes 
contain several of the transcription factor binding sites de-
scribed above, and genes with more than seven transcription 
factor binding sites were selected. 
Because the expression of these genes in colorectal can-
cer is unknown, genes that are upregulated in colorectal 
cancer will be of more significance to the survival time of 
patients. Therefore, upregulated gene sets in colorectal can-
cer needed to be used to filter screened genes above. 
GSE21815 and GSE21510 in the GEO database were used 
to screen upregulated gene sets in colorectal cancer. The 
previous analysis showed that the enrichment outcome of 
235 survival-related genes was correlated with colorectal 
cancer metastasis, therefore data on nine cases of normal 
colorectum and data on 49 cases of colorectal cancer in 
lymph node metastasis were selected from GSE21815 for 
comparison and screening. Additionally, data on 25 cases of 
normal colorectum and data on 39 cases of colorectal cancer 
in lymph node metastasis were selected from GSE21510 for 
comparison and screening. Differentially expressed genes 
were screened using Genespring 11.5. The false discovery 
rate was assessed applying the Benjamini-Hochberg method. 
The P value of screened genes was adjusted to less than 
0.01, and genes in which changes in expression in colorectal 
cancer were more than two times greater than those in nor-
mal colons were selected. 
Screened genes with more than seven transcription factor 
binding sites and upregulated differentially expressed genes 
screened by expression profiles of the above two groups 
were intersected, and then the two groups of filtered genes 
were intersected (Figure 1). The regulatory network analysis 
was conducted on this set of screened genes using STRING 
[3]. Protein nodes in the network were extracted and path-
way enrichment analysis was performed through the KEGG 
database, and proteins involved in the network were clari-
fied. 
2  Results 
2.1  Enrichment results of transcription factor binding 
sites of survival-related genes 
To determine the transcription factor regulation of the 235  
 
Figure 1  Screening process of key genes related to survival time. 
survival-related genes, enrichment analysis was conducted 
on transcription factor binding sites in the transcription reg-
ulatory regions using TFM-Explorer. Twenty-five transcrip-
tion factor binding sites with higher frequency of occur-
rences were screened from the 235 genes. Most transcrip-
tion factor binding sites were located between nucleotides 
20 and 240 upstream of the transcription initiation site. 
Among the 25 enriched transcription factor binding sites,  
SOX2, NFIC and TBP presented a repetition based on dif-
ferent locations, so there were a total of 22 types of tran-
scription factor binding sites: SP1, EGR1, ELK4, EN1, 
ESRRB, ETS1, FOXC1, FOXD1, FOXQ1, GATA2, KLF4, 
NFIC, NFYA, PDX1, RELA, RREB1, SOX2, SOX5, SPIB, 
SRF, T and TBP. This indicates that these transcription fac-
tors might regulate the part of 235 survival-related genes, so 
these transcription factors have an important significance in 
the regulation of the survival time of patients with colorec-
tal cancer. 
2.2  Screening results of key genes related to survival 
Because the transcription regulation of different genes var-
ies, the number of upstream transcription factor binding 
sites of genes also varies. The greater the number of tran-
scription factor binding sites, the more transcription factors 
that regulate the gene, so the more complex the regulatory 
mechanisms that govern the gene expression, and therefore, 
the greater impact of the gene on life activities. Multiple 
transcription factor binding sites usually constitute 
cis-regulatory modules (CRM). Studies have shown that 
CRM-enriched regions are associated with growth-related 
transcription factors, and growth-related transcription fac-
tors also play an important role in the occurrence and de-
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velopment of tumors [4]. Therefore, genes with more bind-
ing sites for the above 25 transcription factors may be more 
important in the development of colorectal cancer, as well 
as the survival time of patients with colorectal cancer. The 
survival-related genes containing the most transcription 
factor binding sites were CREB5 and LOC401317. These 
two genes contain binding sites for 13 of the 25 transcrip-
tion factors. Genes ETV1, MEIS2 and PALLD contain bind-
ing sites for 12 transcription factors, genes EHBP1, MITF 
and TNIK contain binding sites for 11 transcription factors, 
and gene TGFB1I1 contains binding sites for 10 transcrip-
tion factors. Considering the number of screened genes and 
the number of transcription factors, 30 genes containing 
more than seven transcription factor binding sites were se-
lected. Upregulated genes in tumors generally have a posi-
tive impact on the occurrence and development of tumors. If 
the upregulated genes are negatively correlated with the 
survival time of patients, the survival rate of patients will be 
significantly decreased with the increase of gene expression. 
Therefore, the survival time of patients could be assessed 
according to expression of these genes. Second, these genes 
showed positive expressions; their expression was increased 
in colorectal cancer and decreased in normal colorectal tis-
sues, therefore the genes were more conducive in clinical 
diagnosis. During cell signal transduction, the upregulated 
genes could be involved in a cascade of upregulated signals, 
thereby affecting the biological behavior of cells. For ex-
ample, upregulated genes were adopted by GSEA [5] and 
other enrichment tools for the enrichment analysis of dif-
ferent biological phenotypes. Therefore, in this study, fur-
ther screening needed to be conducted on genes with more 
than seven transcription factor binding sites. Upregulated 
gene sets in colorectal cancer were screened using data 
GSE21815 and GSE21510 in the GEO database, and then 
the gene set was used to intersect with the above 30 genes. 
Eight genes were obtained after intersection with upregu-
lated gene sets of data GSE21815, including TGFB1I1, 
STX2, PODXL, KLK6, GRB10, EHBP1, CREB5 and 
ARHGAP5. Nine genes were obtained after the intersection 
with upregulated gene sets of data GSE21510, including 
ZNF83, STX2, PODXL, KLK6, GRB10, ETV1, CREB5, 
CALD1 and EHBP1. Two groups of intersected genes were 
intersected again, and six survival time-related genes with 
more transcription factor binding sites upregulated in colo-
rectal cancer were screened, including STX2, PODXL, 
KLK6, GRB10, EHBP1 and CREB5. 
2.3  Results of survival analysis on survival-related key 
genes 
To further clarify the survival curves of the above six genes, 
a survival analysis was conducted on these genes using ex-
pression profiling data GSE17536 in the GEO database [6]. 
Data GSE17536 and data GSE17538 used in the previous 
study showed a containment relationship. Data GSE17536 
contain expression profiling data of 177 colorectal cancer 
tissues with information on patient survival time. The chip 
platform was Affymetrix Human Genome U133 Plus 2.0 
Array. Expression values of the above six genes of 177 cas-
es were extracted from the expression profiling data. Ex-
pression values of the six genes were sorted from small to 
large, and genes were divided into low, medium and high 
expression groups. Thus, each group had expression values 
of 59 cases, and expression values of the three groups 
showed an increasing relationship. Then, the survival rate of 
the three groups was analyzed using the Kaplan-Meier sur-
vival analysis method to obtain the survival curve (Figure 2). 
Based on changes in gene expression values, CREB5 
(P=0.0036), EHBP1 (P=0.0029), GRB10 (P=0.0396), 
PODXL (P=0.0007), STX2 (P=0.0018) showed a relatively 
apparent difference in the survival rate, all with P values 
less than 0.05. Though the P value of KLK6 (P=0.1069) was 
greater than 0.05, the median survival time of patients with 
low gene expression was significantly higher than those 
with high gene expression. Reports in the literature support 
this result, indicating that KLK6 also correlated with patient 
survival. Almost all results of the survival curve of these six 
genes showed the survival rate was high in patients with 
low expressions of these genes, and low in patients with 
high expressions of these genes, indicating these genes had 
a positive impact on the occurrence and development of 
colorectal cancer. It could be seen from the survival curve 
that the six genes had inconsistent impacts on the tumor; for 
example, the survival rate was relatively high when STX2 
and CREB5 were at a low level of expression. However, the 
survival curve of patients with a medium level of gene ex-
pression was close to that of patients with a high level of 
gene expression, and both survival rates were relatively low, 
indicating that these genes had greater impacts on the de-
velopment of colorectal cancer and thus the survival time of 
patients. 
2.4  Results of regulatory network analysis on key sur-
vival-related genes 
The six screened survival-related genes all exhibit specific 
and independent functions, but their functions are mutually 
coordinated and intermeshed. To further clarify the interac-
tions among the six survival-related genes in the cell sig-
naling network of colorectal cancer, the intermeshing of the 
interacting proteins of the six genes was analyzed using the 
STRING tool. To improve the reliability of interacting pro-
teins, experiment-based protein connection was selected 
from parameter. Regulatory networks among proteins were 
complex, and an excessive number of interacting proteins 
would hinder our ability to obtain conclusive observations, 
so the least number of proteins possible were connected to 
the six proteins to construct a protein interaction network. 
Therefore, the number of proteins was controlled to 30 in 
the network (Figure 3). Then, KEGG pathway enrichment 
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Figure 2  Survival analysis diagram of six survival-related genes. 
was conducted on the above 30 protein nodes in the network 
using the DAVID tool [7] (Table 1). Results showed that 
proteins in the network were mainly involved in the related 
signal regulation of colorectal cancer, focal adhesion, ERbB 
signaling pathways and tumors. GO analysis showed that 
most proteins in the network were localized on the cell 
membrane and were also associated with cell secretion, in-
dicating that proteins in the network were closely related to 
cell adhesion. Therefore, the protein interaction network 
composed of six screened key genes related to the survival 
of colorectal cancer patients was not only associated with 
colorectal cancer, but also more related to colorectal cancer 
metastasis, indicating the six survival-related genes affected 
the survival time of colorectal cancer patients by regulating 
colorectal cancer metastasis. 
3  Discussion 
Colorectal cancer metastasis determines patient survival 
time. The occurrence of metastasis is related to the treat-
ment and prognosis of patients. In this study, the relation-
ship between differences in the expression of these genes 
and patient survival time was clarified by screening key 
genes related to the survival of colorectal cancer patients. 
Through the regulatory network analysis of protein interac-
tions, these genes were found to play a role by regulating 
metastasis-related signaling pathways, further confirming 
the relationship between colorectal cancer metastasis and 
patient survival time. As seen from the survival curve of the 
six screened genes, the survival rate of patients is signifi-
cantly decreased with the increase of gene expression, indi-
cating that high expression of these genes promotes the de-
velopment of colorectal cancer. Furthermore, survival 
curves overlap when STX2 and CREB5 genes are at medium 
and high expression levels, and they show a clear difference 
when genes showed low expression, indicating medium 
expression of these two genes can achieve the same degree 
of impact as high expression on patient survival rate, thus 
indicating that the tumor promoting effect of the two genes 
is more intense. It has been reported that KLK6 [811] and 
PODXL [1214] genes are highly expressed in colorectal 
cancer and correlate with patient prognosis. The survival 
rate will decrease if their expressions are elevated, which is 
consistent with the results of this study and further illus-
trates the reliability of the present findings.  
The survival time is closely related to the treatment and 
prognosis of colorectal cancer patients. Though many genes 
related to the survival time of colorectal cancer patients 
were found in the previous study, these genes affect the 
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Figure 3  Interaction network graphs of six survival-related genes. 
Table 1  Results of KEGG pathway enrichment of 30 interacting protein nodes in the network 
Category Term Count P-value 
KEGG_PATHWAY hsa05210:Colorectal cancer 7 1.37×106 
KEGG_PATHWAY hsa04510:Focal adhesion 9 1.53×106 
KEGG_PATHWAY hsa04012:ErbB signaling pathway 7 1.69×106 
KEGG_PATHWAY hsa05200:Pathways in cancer 10 6.32×106 
KEGG_PATHWAY hsa05214:Glioma 6 7.04×106 
KEGG_PATHWAY hsa05218:Melanoma 6 1.27×105 
KEGG_PATHWAY hsa04130:SNARE interactions in vesicular transport 5 2.12×105 
KEGG_PATHWAY hsa05215:Prostate cancer 6 3.85×105 
KEGG_PATHWAY hsa04660:T cell receptor signaling pathway 6 9.77×105 
KEGG_PATHWAY hsa04144:Endocytosis 7 1.25×104 
KEGG_PATHWAY hsa04722:Neurotrophin signaling pathway 6 1.88×104 
KEGG_PATHWAY hsa04520:Adherens junction 5 3.46×104 
KEGG_PATHWAY hsa04540:Gap junction 5 6.02×104 
KEGG_PATHWAY hsa04912:GnRH signaling pathway 5 8.67×104 
KEGG_PATHWAY hsa04010:MAPK signaling pathway 7 9.37×104 
 
growth and migration of tumor cells by regulating other 
related proteins rather than individually affecting patient 
survival, and many of the regulated genes are associated 
with tumor metastasis. The more regulatory mechanisms the 
genes are involved in, the more critical their functions. Thus, 
by screening genes containing more transcription factor 
binding sites, genes playing a key role in patient survival 
time can be better identified, and changes in the expression 
of these genes will greatly affect the development of tumor 
cells and have an important impact on the survival time and 
prognosis of patients. In this study, six genes closely related 
to the survival time of patients with colorectal cancer were 
screened. By detecting the expression of these genes, the 
prognosis and survival time of patients with colorectal can-
cer may be able to be assessed to determine the best time for 
treatment. 
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